Surrozen (SRZN) EBITDA Margin (2024 - 2026)

Surrozen (SRZN) posted quarterly EBITDA Margin of 209.12% for Q1 2026, up 76250.0% year-over-year from N/an in Q1 2025, and up 91.26% quarter-over-quarter from 2393.75% in Q4 2025.

Surrozen (SRZN) EBITDA Margin (2024 - 2026) Analysis & Trends

Surrozen's EBITDA Margin history runs 3 years deep, the most recent figure standing at 209.12% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 76250.0% year-over-year to 209.12%; the TTM figure through Mar 2026 stood at 573.75% (down 35069.0% YoY), while the FY2025 annual figure was 1210.58%, down 97089.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 209.12%, up from 2393.75% in the prior quarter.
  • The five-year high for EBITDA Margin was 12.32% in Q3 2024, with the low at 2393.75% in Q4 2025.
  • The 3-year median for EBITDA Margin is 971.62% (2025), against an average of 985.51%.
  • The sharpest annual moves came in 2025 and 2026: EBITDA Margin tumbled 111964 bps in 2025, then soared 76250 bps in 2026.
  • Surrozen's EBITDA Margin stood at 1311.76% in 2024, then slumped by 82 bps to 2393.75% in 2025, then surged by 91 bps to 209.12% in 2026.
  • Business Quant data shows SRZN's EBITDA Margin at 209.12% in Q1 2026, 2393.75% in Q4 2025, and 1107.32% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.15%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 31.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 19.06%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -77,569,866.34%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.75%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 17.93%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.36%
10 Surrozen 281.63 Mn 281.63 Mn - -207.40%

Historic Data

Download Data
DateValue
Jun 30, 2026 -207.40%
Mar 31, 2026 -209.12%
Dec 31, 2025 -2,393.75%
Sep 30, 2025 -1,107.32%
Jun 30, 2025 -917.29%
Mar 31, 2025 -971.62%
Dec 31, 2024 -1,311.76%
Sep 30, 2024 12.32%